Information Request


Integral Molecular launches target specificity technology to improve safety of biotherapeutics

September 21, 2016

Integral Molecular announces breakthrough in understanding the functionality of GPCRs, the largest class of drug targets in human disease

August 25, 2016

Integral Molecular Develops B-Cell Cloning Technology to Discover Rare Antibodies against Membrane Proteins

May 26, 2016

Integral Molecular expands intellectual property landscape with international patents protecting key Lipoparticle technology

February 10, 2016

DNA immunization expert Dr. Ross Chambers joins Integral Molecular to Lead Antibody Discovery

December 11, 2015

Integral Molecular identifies key molecular interactions responsible for the effectiveness of the ZMapp™ anti-Ebola virus cocktail

November 12, 2015

Integral Molecular awarded $5.5M by the National Institutes of Health to study Ebola antibodies to aid in vaccine discovery

October 15, 2015

Cat got your tongue? Not according to new research

June 3, 2015

Integral Molecular identifies potent inhibitory antibodies against Chikungunya virus

December 10, 2014

Integral Molecular awarded $3.5M contract from NIH to study Ebola and Hepatitis C virus antibody response

November 13, 2014

Integral Molecular Announces Patent Allowance for Dengue Research Technology

July 17, 2014

Integral Molecular Announces Patent Protecting the use of Lipoparticles for Antibody Discovery

March 28, 2014

Integral Molecular Identifies Potent Antibody Antagonists Against Ion Channel Pain Target P2X3

December 11, 2013

Integral Molecular Announces Issuance of Third Patent Family, Extending Patent Landscape for Key Lipoparticle Technology

November 06, 2013

Integral Molecular Launches MPS Platform for Discovery of Antibodies Targeting Membrane Proteins

April 22, 2013

Patent for Nano-scale Detection of Ion Channel Function in Lipoparticles

February 20, 2013

Integral Molecular and IntelliCyt Corporation Announce Co-marketing Collaboration

December 03, 2012

Integral Molecular and Crystal Bioscience Announce Research Collaboration to Develop Novel GPCR and Ion Channel Antibodies

November 15, 2012

Integral Molecular Announces Patent Allowance for its Membrane Protein Lipoparticle Technology

May 3, 2012

Integral Molecular Announces Lipoparticle Distribution in Japan by Funakoshi

April 25, 2012

Integral Molecular to Expand its Headquarters at the Science Center in Philadelphia

November 15, 2010

Integral Molecular Announces Key Patent Issued on Lipoparticle Technology for Deriving High Concentrations of Cell-free Membrane Proteins

July 27, 2010

Integral Molecular Awarded $9.1 Million Contract from NIAID to Map Epitopes on Viral Pathogens using Shotgun Mutagenesis Mapping Technology

November 3, 2009